Abstract:Cancer immunotherapies using chimeric antigen receptor (CAR) T cells have tremendous potential and proven clinical efficacy against a number of malignancies. Research and development are emerging to deepen the knowledge of CAR T cell efficacy and extend the therapeutic potential of this novel therapy. To this end, functional characterization of CAR T cells plays a central role in consecutive phases across fundamental research and therapeutic development, with increasing needs for standardization. The functional characterization of CAR T cells is typically achieved by assessing critical effector functions, following co-culture with cell lines expressing the target antigen. However, the use of target cell lines poses several limitations, including alterations in cell fitness, metabolic state or genetic drift due to handling and culturing of the cells, which would increase variabilities and could lead to inconsistent results. Moreover, the use of target cell lines can be work and time intensive, and introduce significant background due to the allogenic responses of T cells. To overcome these limitations, we developed a synthetic bead-based platform ("Artificial Targets") to characterize CAR T cell function in vitro . These synthetic microparticles could specifically induce CAR T cell activation, as measured by CD69 and CD137 (4-1BB) upregulation. In addition, engagement with Artificial Targets resulted in induction of multiple effector functions of CAR T cells mimicking the response triggered by target cell lines including cytotoxic activity, as assessed by exposure of CD107a (LAMP-1), expression and secretion of cytokines, as well as cell proliferation. Importantly, in contrast to target cells, stimulation with Artificial Targets showed limited unspecific CAR T cell proliferation. Finally, Artificial Targets demonstrated flexibility to engage multiple costimulatory molecules that can synergistically enhance the CAR T cell function and represented a powerful tool for modulating CAR T cell responses. Collectively, our results show that Artificial Targets can specifically activate CAR T cells for essential effector functions that could significantly advance standardization of functional assessment of CAR T cells, from early development to clinical applications.

A CAR RNA FISH assay to study functional and spatial heterogeneity of chimeric antigen receptor T cells in tissue

A Preclinical Embryonic Zebrafish Xenograft Model to Investigate CAR T Cells in Vivo

Challenges and future perspectives for high-throughput chimeric antigen receptor T cell discovery

Assessment of Chimeric Antigen Receptor T Cytotoxicity by Droplet Microfluidics in Vitro

Dissecting the role of CAR signaling architectures on T cell activation and persistence using pooled screening and single-cell sequencing

DNA origami assembled spheroid for evaluating cytotoxicity and infiltration of chimeric antigen receptor macrophage (CAR-M)

A High-Throughput Method for Characterizing Novel Chimeric Antigen Receptors in Jurkat Cells

Chimeric antigen receptor (CAR)-engineered lymphocytes for cancer therapy

Refining chimeric antigen receptors via barcoded protein domain combination pooled screening

Chimeric antigen receptor-T cell efficacy can be evaluated on an Organ-Chip model system

An innovative single-cell approach for phenotyping and functional genotyping of CAR NK cells

Learning from TCR Signaling and Immunological Synapse Assembly to Build New Chimeric Antigen Receptors (CARs)

Single-cell multiomics dissection of basal and antigen-specific activation states of CD19-targeted CAR T cells

Making Better Chimeric Antigen Receptors for Adoptive T-cell Therapy

Aptamer-Based Nongenetic Reprogramming of CARs Enables Flexible Modulation of T Cell-Mediated Tumor Immunotherapy

Development of an antigen-based approach to noninvasively image CAR T cells in real time and as a predictive tool

Novel FRET-based Immunological Synapse Biosensor for the Prediction of Chimeric Antigen Receptor-T Cell Function

Modeling CAR Response at the Single-Cell Level Using Conditional Optimal Transport

CAR T cell infiltration and cytotoxic killing within the core of 3D breast cancer spheroids under control of antigen sensing in microwell arrays

Artificial Targets: a versatile cell-free platform to characterize CAR T cell function in vitro

CAR T cell infiltration and cytotoxic killing within the core of 3D breast cancer spheroids under the control of antigen sensing in microwell arrays